Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1091 | Pituitary and Neuroendocrinology 3 | ECE2019

Surgical outcomes in acromegaly disease: endoscopic transsphenoidal pituitary surgery

Cozar Miriam , Remon-Ruiz Pablo , Dios-Fuentes Elena , Cozar Miriam , Kaen Ariel , Cardenas Eugenio , Gonzalez Natividad , Martin Ignacio , Roldan Florinda , Fajardo Elena , Cano David , Soto-Moreno Alfonso

Introduction: Endoscopic transsphenoidal pituitary surgery has become the first line method for removal pituitary tumours. A new way to see the surgical field and the cooperation of two neurosurgeons has supposed a revolution in the area.Objetives: Analyse surgical outcomes and complications of a cohort of patients from a single center who underwent ETPS for GH secreting pituitary tumours.Methods: Descriptive prospective-retrospect...

ea0049ep3 | Adrenal cortex (to include Cushing's) | ECE2017

Adrenocortical virilizing tumor in an adult woman in remission after surgical therapy performed more than 12 years ago

Larumbe Terroba , Soto Crespo , Pascual Citores , Fernandez Benito , Aguilar Calero , Goyogana Anacabe , De Linares Urbon Lopez , Vina Ventosa , Olmedo Cuellar , Mures Palacio

Introduction: Adrenocortical carcinomas (ACCs) are rare, frequently aggressive tumors. Pure virilizing carcinomas are infrequent, constituting 5 to 10% in most series.Clinical case: A 36-year-old female consults for 5 years evolution of amenorrhea associated with hirsutism attributed to polycistic ovary syndrome (PCOS) and treated with oral contraceptives during the previous 2 years. There was no other data on virilization, changes in body weight, hypert...

ea0049ep9 | Adrenal cortex (to include Cushing's) | ECE2017

Severe hypertriglyceridemia in relation to toxic levels of mitotane in a patient with stage IV adrenocortical carcinoma (ACC)

Larumbe Terroba , Soto Crespo , Goyogana Anacabe , De Linares Urbon Lopez , Sesmero Amon , Vina Ventosa , Olmedo Cuellar , Garcia Marcos , Roussel Otero , Munoz Almendros

Introduction: The use of mitotane as ACC therapy is associated with multiple adverse effects including hypercholesterolemia due to increased levels of LDL cholesterol. There are no reported cases of severe hypertriglyceridemia (HTG).Clinical case: A 59-year-old male with a personal history of dyslipidemia phenotype IV and pulmonary emphysema, former smoker and drinker was diagnosed with non-functioning left-sided ACC. Left adrenalectomy + left nephrectom...

ea0049ep952 | Pituitary - Clinical | ECE2017

Uncomplicated pregnancy in a patient with McCune Albright syndrome (MAS) and active acromegaly

Larumbe Terroba , Soto Crespo , Goyogana Anacabe , Roman De Luis , De Linares Urbon Lopez , Olmedo Cuellar , Vina Ventosa , Baranda Calleja , Garcia Cabezas

Introduction: The association of acromegaly and polyostotic fibrous dysplasia is a rare entity that presents more difficulties in achieving an effective treatment than classical acromegaly. Pregnancy is infrequent and carries a high risk when acromegaly is active.Clínical case: A 27 year old woman surgically treated for facial asymmetry, without café-au-lait spots or precocious puberty, was evaluated in 1992 after a normal pregnancy. In the bio...

ea0041ep550 | Diabetes therapy | ECE2016

Effects in weight loss and HbA1c after one year of use of dapaglifozina

de Linares Lidia Urbon Lopez , Soto Maria Cristina Crespo , Terroba Concepcion , Ventosa Marta , Martin Tomas , Calleja Maria del Mar , Cuellar Luis Angel

Changes in HbA1c and weight after 1 year on dapaglifozina added to the previous treatment.SGLT2 inhibitors are becoming a common and useful drug to treat type 2 diabetes.The inhibition of the sodium-glucose co transporters (SLGT2) inhibits also the glucose reabsorption in the proximale tubule and increases the glucose excreted in the urine.Therefore hyperglycemia decreases and so does weight as happens with t...

ea0041ep855 | Pituitary - Basic | ECE2016

Biguanides: A new potential therapeutic option for pituitary tumors?

Vazquez-Borrego Ma Carmen , Ibanez-Costa Alejandro , Venegas-Moreno Eva , Galvez Ma Angeles , Soto-Moreno Alfonso , Castano Justo P. , Luque Raul M.

Pituitary adenomas (PA) comprise a commonly underestimated pathology in terms of incidence and associated morbimortality. Somatostatin and dopamine analogs constitute the main medical treatment for PA. However, an appreciable subset of patients are resistant or poorly responsive to these drugs, and hence, the search for new therapies to control tumor growth and/or hormone secretion is crucial. Biguanides such as metformin (MF; commonly used to treat type-2 diabetes), phenformi...

ea0037ep475 | Diabetes (complications & therapy) | ECE2015

Glycaemic control and weight evolution in type 2 diabetic patients with dapagliflozina in addition to their previous treatment

de Linares Lidia Urbon Lopez , Soto Maria Cristina Crespo , Vina Marta Ventosa , Larumbre Concepcion Terroba , Monclus Claudia Martin , Martin Tomas Martin , Olmedo Luis Cuellar

Introduction: From November 2013 it is available in Spain a new drug to treat type 2 diabetes (DM2): dapagliflozina. The new mechanism of action consists in the inhibition of the sodium–glucose co transporters (SLGT2) inhibiting glucose reabsorption in the proximale tubule and increasing glucose excreted in the urine. Therefore hyperglycaemia decreases and so does weight as a consequence of glycosuria. This is a very convenient side effect since DM2 is highly associated w...

ea0035p137 | Calcium and Vitamin D metabolism | ECE2014

Effects of nutritional intervention program on vitamin D serum levels in adolecents

Pastor M Mar Campos , Pardo Ma Dolores Serrano , Soto Ma Luisa Fernandez , de Dios Luna del Castillo Juan , Gomez-Villalba Fernando Escobar , Escobar-Jimenez Fernando

Introduction: Vitamin D deficiency and insufficiency is highly prevalent even in young people. Vitamin D status has been linked to the BMI and insulin resistance.Aim: Determine 25(OH)D concentrations in adolescents before and after nutritional intervention program (NIP) and its relationship to BMI and metabolic syndrome (MS).Methods: We selected 256 secondary school students (127 males) aged between 12 and 16 years from Granada (Sp...

ea0070aep350 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

PHIGNA-DM2 study: Fatty liver and nonalcoholic steatohepatitis prevalence in type 2 diabetes in an andalusian cohort

Jesús Martínez Ortega Antonio , Remon Pablo , Deniz Garcia Alejandro , Ampuero Javier , Romero-Gomez Manuel , Pablo Garcia-Luna Pedro , Soto-Moreno Alfonso

Introduction: Non-alcoholic fatty liver disease (NAFLD) is an underdiagnosed complication in Type 2 Diabetes (T2D). This condition can evolve into steatohepatitis (NASH) and more severe entities such as liver cirrhosis and hepatic failure, being currently the first cause for liver transplantation in our environment. In Andalusian T2D patients, the exact prevalence is still unknown. Our aim is to assess the prevalence of NAFLD/NASH in a cohort of these patients.<p class="ab...

ea0070aep658 | Pituitary and Neuroendocrinology | ECE2020

Prevalence of non-alcoholic fatty liver disease in patients with Cushing disease (CD)

Remon Pablo , Venegas-Moreno Eva , Deniz-Garcia Alejandro , Millan Raquel , Dios-Fuentes Elena , Martin Natalia , Rico Maria C , Madrazo Ainara , Romero-Gómez Manuel , Soto-Moreno Alfonso

Introduction: The prevalence and comorbidities of NAFLD in CD are unknown. There is only one study wich set the prevalence of NAFLD by CT images in 20%1.Objectives: Describe the prevalence of NAFLD and fibrosis in CD and analize predictive biomarkers of NAFLDMethods: Transversal descriptive study. 31 patients with CD; 11 active, 20 cured. Women 24 (77%), men 7 (23%). 54 years mean age. NAFLD was valorated by Hepatic Stea...